Cargando…

A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure

Currently, the early introduction of new antiandrogens is popular for castration-resistant prostate cancer (CRPC). However, adverse events can be severe and their costs are high. Here, we present a patient with CRPC in whom flutamide controlled disease progression for 10 years. This case report show...

Descripción completa

Detalles Bibliográficos
Autores principales: Muramatsu, Tomoaki, Funahashi, Yasuhito, Yamamoto, Akiyuki, Sassa, Naoto, Matsukawa, Yoshihisa, Gotoh, Momokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892669/
https://www.ncbi.nlm.nih.gov/pubmed/31849389
http://dx.doi.org/10.18999/nagjms.81.4.707
_version_ 1783476064158220288
author Muramatsu, Tomoaki
Funahashi, Yasuhito
Yamamoto, Akiyuki
Sassa, Naoto
Matsukawa, Yoshihisa
Gotoh, Momokazu
author_facet Muramatsu, Tomoaki
Funahashi, Yasuhito
Yamamoto, Akiyuki
Sassa, Naoto
Matsukawa, Yoshihisa
Gotoh, Momokazu
author_sort Muramatsu, Tomoaki
collection PubMed
description Currently, the early introduction of new antiandrogens is popular for castration-resistant prostate cancer (CRPC). However, adverse events can be severe and their costs are high. Here, we present a patient with CRPC in whom flutamide controlled disease progression for 10 years. This case report shows that conventional alternative antiandrogens are cost effective and are still an important option for the treatment for CRPC.
format Online
Article
Text
id pubmed-6892669
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nagoya University
record_format MEDLINE/PubMed
spelling pubmed-68926692019-12-17 A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure Muramatsu, Tomoaki Funahashi, Yasuhito Yamamoto, Akiyuki Sassa, Naoto Matsukawa, Yoshihisa Gotoh, Momokazu Nagoya J Med Sci Case Report Currently, the early introduction of new antiandrogens is popular for castration-resistant prostate cancer (CRPC). However, adverse events can be severe and their costs are high. Here, we present a patient with CRPC in whom flutamide controlled disease progression for 10 years. This case report shows that conventional alternative antiandrogens are cost effective and are still an important option for the treatment for CRPC. Nagoya University 2019-11 /pmc/articles/PMC6892669/ /pubmed/31849389 http://dx.doi.org/10.18999/nagjms.81.4.707 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Muramatsu, Tomoaki
Funahashi, Yasuhito
Yamamoto, Akiyuki
Sassa, Naoto
Matsukawa, Yoshihisa
Gotoh, Momokazu
A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure
title A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure
title_full A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure
title_fullStr A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure
title_full_unstemmed A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure
title_short A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure
title_sort case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892669/
https://www.ncbi.nlm.nih.gov/pubmed/31849389
http://dx.doi.org/10.18999/nagjms.81.4.707
work_keys_str_mv AT muramatsutomoaki acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT funahashiyasuhito acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT yamamotoakiyuki acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT sassanaoto acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT matsukawayoshihisa acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT gotohmomokazu acaseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT muramatsutomoaki caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT funahashiyasuhito caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT yamamotoakiyuki caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT sassanaoto caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT matsukawayoshihisa caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure
AT gotohmomokazu caseofadvancedprostatecancercontrolledforthelongtermbyflutamideafterbicalutamidefailure